Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Ifeanyichukwu Ifechidere: Advancing Education, Research, and Laboratory Excellence in APS
Ifeanyichukwu Ifechidere/LinkedIn
Jun 22, 2026, 20:47

Ifeanyichukwu Ifechidere: Advancing Education, Research, and Laboratory Excellence in APS

Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:

“June is Antiphospholipid Syndrome (APS) Awareness Month – an opportunity to shine a light on a complex and often misunderstood autoimmune disorder that can have life-changing consequences.

As a biomedical scientist working in coagulation, I regularly see how critical accurate laboratory testing is in identifying patients at risk of APS.

What is Antiphospholipid Syndrome (APS)?

APS is an autoimmune condition in which the body’s immune system produces antibodies that mistakenly target phospholipid-binding proteins in the blood. These antibodies increase the risk of abnormal blood clot formation in both veins and arteries.

The condition is associated with three key laboratory markers:

  • Lupus anticoagulant (LA)
  • Anticardiolipin antibodies (aCL)
  • Anti-β2 glycoprotein I antibodies (anti-β2GPI)

A diagnosis requires both clinical and laboratory criteria, highlighting the essential role of collaboration between clinicians and laboratory professionals.

How does APS affect someone’s life?

For many individuals, APS can be life-altering.

It may lead to:

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)
  • Stroke or transient ischaemic attack (TIA)
  • Recurrent pregnancy loss
  • Pregnancy complications such as pre-eclampsia and placental insufficiency

Beyond the physical risks, APS can significantly impact mental wellbeing, family planning, employment, and quality of life. Many patients face long diagnostic journeys before receiving answers.

Why laboratory testing matters

Detecting APS requires specialised coagulation and immunology testing, often repeated after 12 weeks to confirm persistent antibody positivity. Accurate testing, interpretation, and adherence to guidelines are essential to avoid misdiagnosis and ensure appropriate patient management.

Raising awareness matters

Earlier recognition of APS can prevent serious thrombotic events and improve pregnancy outcomes. Increased awareness among healthcare professionals, patients, and the public is vital to reducing delays in diagnosis and treatment.

This APS Awareness Month, let’s recognise the patients living with this condition every day and continue advancing education, research, and laboratory excellence to support better outcomes.”

Ifeanyichukwu Ifechidere

Find more posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.

aCL anti-β2GPI Anticardiolipin Antibodies Antiphospholipid Syndrome APS APS Awareness Month bleeding disorders Blood coagulation deep vein thrombosis DVT Health Hematology Hemostasis News Hemostasis Today Ifeanyichukwu Ifechidere LA Lupus Anticoagulant Medicine PE placental insufficiency Pre-eclampsia Pregnancy Pulmonary embolism stroke thrombosis TIA transient ischaemic attack
NewsFeed